相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Universal Pharmacological-Based List of Drugs with Anticholinergic Activity
Marta Lavrador et al.
PHARMACEUTICS (2023)
Neuropsychiatric Symptoms as Predictor of Poor Clinical Outcome in Patients With Vascular Cognitive Impairment
Yoni C. P. Sep et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2022)
Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review
Angela Lisibach et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Prevalence of psychotropic polypharmacy in nursing home residents with dementia: a meta-analysis
Dylan J. Jester et al.
INTERNATIONAL PSYCHOGERIATRICS (2021)
Current use of anticholinergic medications in a large naturalistic sample of psychiatric patients
Sermin Toto et al.
JOURNAL OF NEURAL TRANSMISSION (2021)
Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US
Donovan T. Maust et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Interventions to Reduce Anticholinergic Burden in Adults Aged 65 and Older: A Systematic Review
Athagran Nakham et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2020)
The individual course of neuropsychiatric symptoms in people with Alzheimer's and Lewy body dementia: 12-year longitudinal cohort study
Audun Osland Vik-Mo et al.
BRITISH JOURNAL OF PSYCHIATRY (2020)
Apathy and anxiety are early markers of Alzheimer's disease
Maurits Johansson et al.
NEUROBIOLOGY OF AGING (2020)
Are Anticholinergic Medications Associated With Increased Risk of Dementia and Behavioral and Psychological Symptoms of Dementia? A Nationwide 15-Year Follow-Up Cohort Study in Taiwan
Yia-Ping Liu et al.
FRONTIERS IN PHARMACOLOGY (2020)
The role of nicotinic cholinergic neurotransmission in delusional thinking
Michael Caton et al.
NPJ SCHIZOPHRENIA (2020)
Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus
Helen C. Kales et al.
INTERNATIONAL PSYCHOGERIATRICS (2019)
Psychological and Cognitive Markers of Behavioral Variant Frontotemporal Dementia-A Clinical Neuropsychologist's View on Diagnostic Criteria and Beyond
Andreas Johnen et al.
FRONTIERS IN NEUROLOGY (2019)
Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia
Rachel Halpern et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2019)
Threshold for a Reduction in Anticholinergic Burden to Decrease Behavioral and Psychological Symptoms of Dementia
Yacine Jaidi et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2019)
DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities
Nagham Ailabouni et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2019)
Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders
Sean P. Moran et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Anticholinergic Drugs in Geriatric Psychopharmacology
Jorge Lopez-Alvarez et al.
FRONTIERS IN NEUROSCIENCE (2019)
Reduction of the Anticholinergic Burden Makes It Possible to Decrease Behavioral and Psychological Symptoms of Dementia
Yacine Jaidi et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2018)
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
Harald Hampel et al.
BRAIN (2018)
Anticholinergic Drug Burden Tools/Scales and Adverse Outcomes in Different Clinical Settings: A Systematic Review of Reviews
Tomas J. Welsh et al.
DRUGS & AGING (2018)
Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy
Stuti Verma et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2018)
Regulation of Phosphorylation of AMPA Glutamate Receptors by Muscarinic M4 Receptors in the Striatum In vivo
Li-Min Mao et al.
NEUROSCIENCE (2018)
Risk of hospitalization associated with anticholinergic medication for patients with dementia
Shuichi Watanabe et al.
PSYCHOGERIATRICS (2018)
Risk of hospitalization associated with anticholinergic medication for patients with dementia
Shuichi Watanabe et al.
PSYCHOGERIATRICS (2018)
Anticholinergic Burden and Risk of Stroke and Death in People with Different Types of Dementia
Edwin C. K. Tan et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics
Amanda J. Cross et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A metaanalysis
Ruey Chen et al.
PLOS ONE (2017)
Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders
Virginie Dauphinot et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
The Vascular Impairment of Cognition Classification Consensus Study
Olivia A. Skrobot et al.
ALZHEIMERS & DEMENTIA (2017)
The effect of memantine on sleep architecture and psychiatric symptoms in patients with Alzheimer's disease
Ichiro Ishikawa et al.
ACTA NEUROPSYCHIATRICA (2016)
The effect of memantine on sleep architecture and psychiatric symptoms in patients with Alzheimer's disease
Ichiro Ishikawa et al.
ACTA NEUROPSYCHIATRICA (2016)
The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis
Qing-Fei Zhao et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects
Jennifer E. Davoren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Anticholinergic Medication Burden and 5-Year Risk of Hospitalization and Death in Nursing Home Elderly Residents With Coronary Artery Disease
Davide L. Vetrano et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2016)
Trajectories of Depressive Symptoms in Older Adults and Risk of Dementia
Allison R. Kaup et al.
JAMA PSYCHIATRY (2016)
Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review
Mohammed Saji Salahudeen et al.
BMC GERIATRICS (2015)
Multivariate models of subjective caregiver burden in dementia: A systematic review
Jacqueline van der Lee et al.
AGEING RESEARCH REVIEWS (2014)
Striatal Cholinergic Neurotransmission Requires VGLUT3
Alexandra B. Nelson et al.
JOURNAL OF NEUROSCIENCE (2014)
Multiple Anticholinergic Medication Use and Risk of Hospital Admission for Confusion or Dementia
Lisa M. Kalisch Ellett et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2014)
What is frontotemporal dementia?
Alexander Kurz et al.
MATURITAS (2014)
Neuropsychiatric Symptoms as Risk Factors for Progression From CIND to Dementia: The Cache County Study
M. E. Peters et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2013)
Association of Anticholinergic Burden with Cognitive and Functional Status in a Cohort of Hospitalized Elderly: Comparison of the Anticholinergic Cognitive Burden Scale and Anticholinergic Risk Scale Results from the REPOSI Study
Luca Pasina et al.
DRUGS & AGING (2013)
The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction
Pradeep J. Nathan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
α-Synucleinopathy phenotypes
Heather McCann et al.
PARKINSONISM & RELATED DISORDERS (2013)
GABAergic circuits mediate the reinforcement-related signals of striatal cholinergic interneurons
Daniel F. English et al.
NATURE NEUROSCIENCE (2012)
Memantine effects on behaviour in moderately severe to severe Alzheimer's disease: a post-marketing surveillance study
Francesca Clerici et al.
NEUROLOGICAL SCIENCES (2012)
Loss of Muscarinic M1 Receptor Exacerbates Alzheimer's Disease-Like Pathology and Cognitive Decline
Rodrigo Medeiros et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Paying Attention to Pharmacokinetic and Pharmacodynamic Mechanisms to Progress in the Area of Anticholinergic Use in Geriatric Patients
J. de Leon
CURRENT DRUG METABOLISM (2011)
Influence of Anticholinergic Activity in Serum on Clinical Symptoms of Alzheimer's Disease
Koji Hori et al.
NEUROPSYCHOBIOLOGY (2011)
Single Particle Tracking of α7 Nicotinic AChR in Hippocampal Neurons Reveals Regulated Confinement at Glutamatergic and GABAergic Perisynaptic Sites
Thomas Buerli et al.
PLOS ONE (2010)
The M3-muscarinic receptor regulates learning and memory in a receptor phosphorylation/arrestin-dependent manner
Benoit Poulin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Association between prescribing of antimuscarinic drugs and antimuscarinic adverse effects in older people
Clare V Bostock et al.
Expert Review of Clinical Pharmacology (2010)
Memantine Therapy of Behavioral Symptoms in Community-Dwelling Patients with Moderate to Severe Alzheimer's Disease
George T. Grossberg et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2009)
A Selective Allosteric Potentiator of the M1 Muscarinic Acetylcholine Receptor Increases Activity of Medial Prefrontal Cortical Neurons and Restores Impairments in Reversal Learning
Jana K. Shirey et al.
JOURNAL OF NEUROSCIENCE (2009)
A cog in cognition: How the α7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits
Steven C. Leiser et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Efficacy of memantine on behavioral and psychological symptoms related to dementia: A systematic meta-analysis
Ian D. Maidment et al.
ANNALS OF PHARMACOTHERAPY (2008)
Behavioral and psychological symptoms in dementia with Lewy-bodies (DLB): Frequency and relationship with disease severity and motor impairment
B. Borroni et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2008)
The anticholinergic risk scale and anticholinergic adverse effects in older persons
James L. Rudolph et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Galantamine in frontotemporal dementia and primary progressive aphasia
A. Kertesz et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2008)
Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study
Martin Steinberg et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Genetic Variation in the alpha 7 Nicotinic Acetylcholine Receptor is Associated with Delusional Symptoms in Alzheimer's Disease
Robyn Carson et al.
NEUROMOLECULAR MEDICINE (2008)
Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia
W. Y. Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Loss of [H-3]4-DAMP binding to muscarinic receptors in the orbitofrontal cortex of Alzheimer's disease patients with psychosis
S. W. Y. Tsang et al.
PSYCHOPHARMACOLOGY (2008)
Drugs with anticholinergic properties as a risk factor for psychosis in patients affected by Alzheimer's disease
I. Cancelli et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Heterogeneity and complexity of native brain nicotinic receptors
Cecilia Gotti et al.
BIOCHEMICAL PHARMACOLOGY (2007)
The novel α7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents
Frank G. Boess et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies
Paul T. Francis et al.
MOVEMENT DISORDERS (2007)
Preliminary findings: Behavioral worsening on donepezil in patients with frontotemporal dementia
Mario F. Mendez et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2007)
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Juergen Wess et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
The anticholinergic drug scale as a measure of drug-related anticholinergic burden: Associations with serum anticholinergic activity
Ryan M. Carnahan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia
Sean J. Colloby et al.
NEUROIMAGE (2006)
A critical role for β cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo
Dinesh Gautam et al.
CELL METABOLISM (2006)
Behavioural changes and psychological symptoms in dementia disorders
I McKeith et al.
LANCET NEUROLOGY (2005)
Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies
T Teaktong et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease
M. Garcia-Alloza et al.
NEUROPSYCHOLOGIA (2005)
Muscarinic receptor agonists and antagonists in the treatment of Alzheimer's Disease
JW Clader et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
AR-R 17779 improves social recognition in rats by activation of nicotinic α7 receptors
M van Kampen et al.
PSYCHOPHARMACOLOGY (2004)
M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission:: relevance to the pathophysiology and treatment of related central nervous system pathologies
ET Tzavara et al.
FASEB JOURNAL (2004)
Cholinergic denervation in a pure multi-infarct state - Observations on CADASIL
M Mesulam et al.
NEUROLOGY (2003)
Decreased cerebrospinal fluid acetylcholinesterase in patients with subcortical ischemic vascular dementia
A Wallin et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2003)
Visual hallucinations are associated with lower αbungarotoxin binding in dementia with Lewy bodies
JA Court et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2001)
Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications
MR Picciotto et al.
PHARMACOLOGY & THERAPEUTICS (2001)
Cholinergic deficits contribute to behavioral disturbance in patients with dementia
SL Minger et al.
NEUROLOGY (2000)
分享论文
